Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Examining Sex-Differentiated Genetic Effects Across Neuropsychiatric and Behavioral Traits

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Dysregulated Lipid Metabolism Precedes Onset of Psychosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Schizophrenia Working Group of the Psychiatric Genomics Consortium
  • Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
  • Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
  • Sex Differences Cross-Disorder Analysis Group of the Psychiatric Genomics Consortium
  • iPSYCH
View graph of relations

BACKGROUND: Sex differences in incidence and/or presentation of schizophrenia (SCZ), major depressive disorder (MDD), and bipolar disorder (BIP) are pervasive. Previous evidence for shared genetic risk and sex differences in brain abnormalities across disorders suggest possible shared sex-dependent genetic risk.

METHODS: We conducted the largest to date genome-wide genotype-by-sex (G×S) interaction of risk for these disorders using 85,735 cases (33,403 SCZ, 19,924 BIP, and 32,408 MDD) and 109,946 controls from the PGC (Psychiatric Genomics Consortium) and iPSYCH.

RESULTS: Across disorders, genome-wide significant single nucleotide polymorphism-by-sex interaction was detected for a locus encompassing NKAIN2 (rs117780815, p = 3.2 × 10-8), which interacts with sodium/potassium-transporting ATPase (adenosine triphosphatase) enzymes, implicating neuronal excitability. Three additional loci showed evidence (p < 1 × 10-6) for cross-disorder G×S interaction (rs7302529, p = 1.6 × 10-7; rs73033497, p = 8.8 × 10-7; rs7914279, p = 6.4 × 10-7), implicating various functions. Gene-based analyses identified G×S interaction across disorders (p = 8.97 × 10-7) with transcriptional inhibitor SLTM. Most significant in SCZ was a MOCOS gene locus (rs11665282, p = 1.5 × 10-7), implicating vascular endothelial cells. Secondary analysis of the PGC-SCZ dataset detected an interaction (rs13265509, p = 1.1 × 10-7) in a locus containing IDO2, a kynurenine pathway enzyme with immunoregulatory functions implicated in SCZ, BIP, and MDD. Pathway enrichment analysis detected significant G×S interaction of genes regulating vascular endothelial growth factor receptor signaling in MDD (false discovery rate-corrected p < .05).

CONCLUSIONS: In the largest genome-wide G×S analysis of mood and psychotic disorders to date, there was substantial genetic overlap between the sexes. However, significant sex-dependent effects were enriched for genes related to neuronal development and immune and vascular functions across and within SCZ, BIP, and MDD at the variant, gene, and pathway levels.

Original languageEnglish
JournalBiological Psychiatry
ISSN0006-3223
DOIs
Publication statusPublished - 23 Mar 2021

Bibliographical note

Publisher Copyright:
© 2021 Society of Biological Psychiatry

    Research areas

  • Bipolar disorder, Genome-wide association study, Genotype-by-sex interaction, Major depressive disorder, Schizophrenia, Sex differences

ID: 68084437